* Says Oncurious NV and Bioinvent partner with U.S. research consortium to accelerate phase I/IIa clinical development of TB-403 Source text: http://bit.ly/251lYUL Further company coverage: (Gdynia…

The post BRIEF-Thrombogenics says Oncurious and Bioinvent partner with U.S. research consortium appeared first on NASDAQ.